evidence: The diphtheria-tetanus-acellular pertussis (DTaP) vaccine is licensed. This vaccine is an acellular vaccine, which causes fewer side effects than the whole-cell DTP vaccine. The DTaP vaccine eventually replaces the DTP vaccine. In 1996, the Advisory Committee on Immunization Practices (ACIP) will recommend DTaP in infants.